– Breadth of Alto’s pipeline and Precision Psychiatry Platform™ will be highlighted across twelve posters and presentations at the Society of Biological Psychiatry and American Society of Clinical ...
Investments aren’t just numbers—they’re stories, and you can tell those stories with Presentation Studio. This Morningstar Direct module lets you use Morningstar data and analytics to distill complex ...
OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda (TSE: 4502/NYSE:TAK) will present today positive results from its Phase 2b trial of TAK-861 in narcolepsy type 1 (NT1) as late-breaking data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results